These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9027989)

  • 1. Structural analysis of ricin and implications for inhibitor design.
    Robertus JD; Yan X; Ernst S; Monzingo A; Worley S; Day P; Hollis T; Svinth M
    Toxicon; 1996; 34(11-12):1325-34. PubMed ID: 9027989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The X-ray structure of ricin A chain with a novel inhibitor.
    Bai Y; Monzingo AF; Robertus JD
    Arch Biochem Biophys; 2009 Mar; 483(1):23-8. PubMed ID: 19138659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based identification of a ricin inhibitor.
    Yan X; Hollis T; Svinth M; Day P; Monzingo AF; Milne GW; Robertus JD
    J Mol Biol; 1997 Mar; 266(5):1043-9. PubMed ID: 9086280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of ricin inhibitors.
    Jasheway K; Pruet J; Anslyn EV; Robertus JD
    Toxins (Basel); 2011 Oct; 3(10):1233-48. PubMed ID: 22069693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.
    Miller DJ; Ravikumar K; Shen H; Suh JK; Kerwin SM; Robertus JD
    J Med Chem; 2002 Jan; 45(1):90-8. PubMed ID: 11754581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Structural Characterization of Ricin Inhibitors Targeting Ribosome Binding Using Fragment-Based Methods and Structure-Based Design.
    Li XP; Harijan RK; Cao B; Kahn JN; Pierce M; Tsymbal AM; Roberge JY; Augeri D; Tumer NE
    J Med Chem; 2021 Oct; 64(20):15334-15348. PubMed ID: 34648707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new classes of ricin toxin inhibitors by virtual screening.
    Bai Y; Watt B; Wahome PG; Mantis NJ; Robertus JD
    Toxicon; 2010 Sep; 56(4):526-34. PubMed ID: 20493201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-conjugated pterins as inhibitors of ricin toxin A.
    Saito R; Pruet JM; Manzano LA; Jasheway K; Monzingo AF; Wiget PA; Kamat I; Anslyn EV; Robertus JD
    J Med Chem; 2013 Jan; 56(1):320-9. PubMed ID: 23214944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Substituted pterins provide a new direction for ricin A chain inhibitors.
    Pruet JM; Jasheway KR; Manzano LA; Bai Y; Anslyn EV; Robertus JD
    Eur J Med Chem; 2011 Sep; 46(9):3608-15. PubMed ID: 21641093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity.
    Shuntao W; Jiannan F; Jianwei G; Leiming G; Yan L; Yingxun S; Weisong Q; Meiru H; Gencheng H; Beifen S
    Mol Immunol; 2006 Apr; 43(11):1912-9. PubMed ID: 16343623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Shoemaker CB; Mantis NJ
    Proteins; 2016 Aug; 84(8):1162-72. PubMed ID: 27159829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure and action of ricin, a cytotoxic N-glycosidase.
    Robertus J
    Semin Cell Biol; 1991 Feb; 2(1):23-30. PubMed ID: 1954340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin Inhibitors.
    Botelho FD; Dos Santos MC; Gonçalves ADS; Kuca K; Valis M; LaPlante SR; França TCC; de Almeida JSFD
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33256167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ricin A-chain inhibitors resembling the oxacarbenium ion transition state.
    Tanaka KS; Chen XY; Ichikawa Y; Tyler PC; Furneaux RH; Schramm VL
    Biochemistry; 2001 Jun; 40(23):6845-51. PubMed ID: 11389598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Relative Binding Affinity of Ricin Toxin A Inhibitors by Using Molecular Docking and Nonequilibrium Work.
    Chaves EJF; Padilha IQM; Araújo DAM; Rocha GB
    J Chem Inf Model; 2018 Jun; 58(6):1205-1213. PubMed ID: 29750861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ricin: current understanding and prospects for an antiricin vaccine.
    Marsden CJ; Smith DC; Roberts LM; Lord JM
    Expert Rev Vaccines; 2005 Apr; 4(2):229-37. PubMed ID: 15889996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray analysis of substrate analogs in the ricin A-chain active site.
    Monzingo AF; Robertus JD
    J Mol Biol; 1992 Oct; 227(4):1136-45. PubMed ID: 1433290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation analysis of formycin 5'-monophosphate analog substrates in the ricin A-chain active site.
    Olson MA; Scovill JP; Hack DC
    J Comput Aided Mol Des; 1995 Jun; 9(3):226-36. PubMed ID: 7561975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state.
    Roday S; Amukele T; Evans GB; Tyler PC; Furneaux RH; Schramm VL
    Biochemistry; 2004 May; 43(17):4923-33. PubMed ID: 15109250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
    Lambert JM; Goldmacher VS; Collinson AR; Nadler LM; Blättler WA
    Cancer Res; 1991 Dec; 51(23 Pt 1):6236-42. PubMed ID: 1718599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.